Posted on 11/14/16
Juno Therapeutics On a Roll in Q3 with Celgene's Cash and Lift of Clinical Hold
Juno Therapeutics (NASDAQ:JUNO) announced its third-quarter earnings results on Wednesday after the market closed. Shares of the biotech were already soaring in response to the outcome . . .
Posted on 11/13/16
Delcath Announces Third Quarter Financial Results
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces financial results for the three and . . .
Posted on 11/13/16
Pfizer Announces Major Expansion of Humanitarian Assistance Program
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today a major expansion of its humanitarian assistance program enabling broader access to its vaccine, Prevenar 13, in humanitarian emergency . . .
Posted on 11/11/16
MetLife Recognized as Military Friendly Employer Fifth Year in a Row
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced it has been recognized as a Military Friendly® Employer by G.I. Jobs magazine. This is the fifth year . . .
Posted on 11/11/16
Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday
What happenedShares of Allergan (NYSE:AGN), Horizon Pharma plc (NASDAQ:HZNP), and Pfizer(NYSE:PFE) all surged higher yesterday on the news that Donald Trump would become the next president . . .
Posted on 11/10/16
Better Buy: Gilead Sciences Inc. vs. Pfizer Inc.
Your time horizon matters when picking a stock.Gilead Sciences (NASDAQ:GILD), for example, gave investors five times the returns of Pfizer (NYSE:PFE) over the past five years. . . .
Posted on 11/10/16
Trump's Win Is Causing a Tremendous Sell-Off in Hospital Stocks
IMAGE SOURCE: GETTY IMAGES.What happenedAfter Americans elected Donald Trump President, shares in HCA Holdings (NYSE:HCA), Community Health Systems (NYSE:CYH), and Tenet Healthcare Corp. (NYSE:THC) are falling . . .
Posted on 11/10/16
Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks?
Pharma stocks, so far, are reacting positively to the news the Donald Trump has upended Hillary Clinton to become the 45th President of the United States . . .
Posted on 11/9/16
Alexion Provides Update on Form 10-Q Filing
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a Form 12b-25 Notification . . .
Posted on 11/9/16
Eagle Pharmaceuticals Reports Third Quarter 2016 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announced its financial results for the three- and nine-months ended September 30, 2016. Highlights of and subsequent to . . .
Posted on 11/9/16
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s . . .
Posted on 11/9/16
Better Buy: Amgen Inc. vs. Johnson & Johnson
They're two of the premiere long-term winners among healthcare stocks. They both have deep pipelines and deep pocketbooks. And they both reward investors with nice dividends. . . .
Posted on 11/9/16
Regeneron Pharmaceuticals, Inc. Dropped 14.3% in October -- Here's Why
IMAGE SOURCE: GETTY IMAGES.What happenedInvestors in Regeneron Pharmaceuticals (NASDAQ:REGN) had a rough October. Shares of the biotech giant fell 14.3% during the month, according to data . . .
Posted on 11/8/16
Cognizant Technology Sees Profit Growth Ahead
Many corporate customers turn to Cognizant Technology Solutions (NASDAQ:CTSH) to help them make better use of the information technology resources that have become available in recent . . .
Posted on 11/8/16
Here's Why Amicus Therapeutics, Inc. Soared As Much As 20% Despite an Earnings Miss
IMAGE SOURCE: GETTY IMAGES.What happenedShares of Amicus Therapeutics (NASDAQ:FOLD), a biopharmaceutical company focused on the development of therapies primarily designed to treat ultra-rare and rare diseases, . . .
Posted on 11/8/16
Is Pfizer Inc.'s 6.4% Drop in October the Beginning of a Long Downtrend?
IMAGE SOURCE: GETTY IMAGES.What happenedShares of global drug giant Pfizer (NYSE:PFE) had a pretty miserable October, ending lower by 6.4% based on data from S&P Global . . .
Posted on 11/8/16
Celldex Therapeutics, Inc. Watches Its Cash in Q3, Ready to Expand
IMAGE SOURCE: GETTY IMAGES.There hasn't been much good news for Celldex Therapeutics (NASDAQ:CLDX) in 2016. Failure of Rintega in a late-stage study resulted in a loss . . .
Posted on 11/8/16
SAFE-BioPharma Partnership Named Winner of HHS "Move Health Data Forward Challenge"
TEANECK, N.J.--(BUSINESS WIRE)--The Department of Health and Humans Services’ Office of the National Coordinator for Health Information Technology (ONC) named a proposal from SAFE-BioPharma, Resilient Network . . .
Posted on 11/8/16
Takeda and Koneksa Health Announce Strategic Collaboration
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of . . .
Posted on 11/7/16
Progenics Announces $50 Million RELISTOR Royalty-Backed Financing
NEW YORK, Nov. 07, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, . . .
Posted on 11/7/16
3 Things You Really Need to Know About Regeneron Pharmaceuticals' Q3 Results
Can Regeneron Pharmaceuticals (NASDAQ:REGN) stop the slide?That's the question that was on investors' minds as the biotech prepared to announce its third-quarter results before the market . . .
Posted on 11/7/16
PAVmed Partners with Leading Academic Institutions
NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has signed a definitive licensing agreement with a . . .
Posted on 11/4/16
Novartis Takes Aim at Pfizer
Novartis' (NYSE:NVS) application for FDA approval of ribociclib for first-line use alongside letrozole, in patients who have advanced breast cancer with an amenable genetic makeup, has . . .
Posted on 11/4/16
Amerigroup New Jersey Joins National Comprehensive Primary Care Plus Initiative
ISELIN, N.J.--(BUSINESS WIRE)--Amerigroup New Jersey has been selected as a payer participant in the Centers for Medicare & Medicaid Services’ Comprehensive Primary Care Plus (CPC+) initiative, . . .
Posted on 11/3/16
Pfizer Delivers Another Solid Quarter Of Organic Growth
IMAGE SOURCE: PFIZER, INC.Pfizer Inc.'s (NYSE:PFE) third-quarter performance shows that the company's finally overcoming the multiyear drag on sales caused by the patent expiration of Lipitor . . .
New York
